Yes , with Dr Pestell criteria so many less patients could benefit from Leronlimab , this is why they dismissed our very first emergency patient..
Dr Patterson wanted to keep her on our drug , but the protocol design by Dr Pestell prevented that... I am so sorry about it..

Now it is looking that many , many patients with metastatic cancers will be proper patients for a studies. and treatment all together......and hopefully patients will benefit...

And as I always say , we don't know , which one of us , or people we love will be the next patient ...




IMO as always ...